Podcasts about opioids

This week we talk about OxyContin, opium, and the British East India Company.We also discuss isotonitazene, fentanyl, and Perdue.Recommended Book: The Thinking Machine by Stephen WittTranscriptOpioids have been used as painkillers by humans since at least the Neolithic period; there's evidence that people living in the Iberian and Italian Peninsulas kept opium poppy seeds with them, and there's even more evidence that the Ancient Greeks were big fans of opium, using it to treat pain and as a sleep aid.Opium was the only available opioid for most of human history, and it was almost always considered to be a net-positive, despite its downsides. It was incorporated into a mixture called laudanum, which was a blend of opium and alcohol, in the 17th century, and that helped it spread globally as Europeans spread globally, though it was also in use locally, elsewhere, especially in regions where the opium poppy grew naturally.In India, for instance, opium was grown and often used for its painkilling properties, but when the British East India Company took over, they decided to double-down on the substance as a product they could monopolize and grow into a globe-spanning enterprise.They went to great lengths to expand production and prevent the rise of potential competitors, in India and elsewhere, and they created new markets for opium in China by forcing the product onto Chinese markets, initially via smuggling, and then eventually, after fighting a series of wars focused on whether or not the British should be allowed to sell opium on the Chinese market, the British defeated the Chinese. And among other severely unbalanced new treaties, including the ceding of the Kowloon peninsula to the British as part of Hong Kong, which they controlled as a trading port, and the legalization of Christians coming into the country, proselytizing, and owning property, the Chinese were forced to accept the opium trade. This led to generations of addicts, even more so than before, when opium was available only illicitly, and it became a major bone of contention between the two countries, and informed China's relationship with the world in general, especially other Europeans and the US, moving forward.A little bit later, in the early 1800s, a German pharmacist was able to isolate a substance called morphine from opium. He published a paper on this process in 1817, and in addition to this being the first alkaloid, the first organic compound of this kind to be isolated from a medicinal plant, which was a milestone in the development of modern drug discovery, it also marked the arrival of a new seeming wonder drug, that could ease pain, but also help control cold-related symptoms like coughing and gut issues, like diarrhea. Like many such substances back in the day, it was also often used to treat women who were demonstrating ‘nervous character,' which was code for ‘behaving in ways men didn't like or understand.'Initially, it was thought that, unlike with opium, morphine wasn't addictive. And this thinking was premised on the novel application method often used for morphine, the hypermedia needle, which arrived a half-century after that early 1800s isolation of morphine from opium, but which became a major driver of the new drug's success and utility. Such drugs, derived scientifically rather than just processing a plant, could be administered at specific, controllable doses. So surely, it was thought, this would alleviate those pesky addictive symptoms that many people experienced when using opioids in a more natural, less science-y way.That, of course, turned out not to be the case. But it didn't stop the progression of this drug type, and the further development of more derivations of it, including powerful synthetic opioids, which first hit the scene in the mid-20th century.What I'd like to talk about today is the recent wave of opioid addictions, especially but not exclusively in the US, and the newest concern in this space, which is massively more powerful than anything that's come before.—As I mentioned, there have been surges in opioid use, latent and externally forced, throughout modern human history.The Chinese saw an intense wave of opioid addiction after the British forced opium onto their markets, to the point that there was a commonly held belief that the British were trying to overthrow and enslave the Chinese by weighing them down with so many addicts who were incapable of doing much of anything; which, while not backed by the documentation we have from the era—it seems like they were just chasing profits—is not impossible, given what the Brits were up to around the world at that point in history.That said, there was a huge influx in opioid use in the late-1980s, when a US-based company called Purdue Pharma began producing and pushing a time-released opioid medication, which really hit the big-time in 1995, when they released a version of the drug called OxyContin.OxyContin flooded the market, in part because it promised to help prevent addiction and accidental overdose, and in part because Purdue was just really, really good at marketing it; among other questionable and outright illegal things it did as part of that marketing push, it gave kickbacks to doctors who prescribed it, and some doctors did so, a lot, even when patients didn't need it, or were clearly becoming addicted.By the early 2000s, Purdue, and the Sackler family that owned the company, was spending hundreds of millions of dollars a year to push this drug, and they were making billions a year in sales.Eventually the nature of Purdue's efforts came to light, there were a bunch of trials and other legal hearings, some investigative journalists exposed Purdue's foreknowledge of their drug's flaws, and there was a big government investigation and some major lawsuits that caused the collapse of the company in 2019—though they rebranded in 2021, becoming Knoa Pharma.All of which is interesting because much like the forced legalization of opium on Chinese markets led to their opioid crisis a long time ago, the arrival of this incredibly, artificially popular drug on the US market led to the US's opioid crisis.The current bogeyman in the world of opioids—and I say current because this is a fast-moving space, with new, increasingly powerful or in some cases just a lot cheaper drugs arriving on the scene all the time—is fentanyl, which is a synthetic opioid that's about 30-50 times more potent than heroin, and about 100 times as potent as morphine. It has been traditionally used in the treatment of cancer patients and as a sedative, and because of how powerful it is, a very small amount serves to achieve the desired, painkilling effect.But just like other opioids, its administration can lead to addiction, people who use it can become dependent and need more and more of it to get the same effects, and people who have too much of it can experience adverse effects, including, eventually, death.This drug has been in use since the 1960s, but illicit use of fentanyl began back in the mid-1970s, initially as its own thing, but eventually to be mixed in with other drugs, like heroin, especially low-quality versions of those drugs, because a very small amount of fentanyl can have an incredibly large and potent effect, making those other drugs seem higher quality than they are.That utility is also this drug's major issue, though: it's so potent that a small amount of it can kill, and even people with high opioid tolerances can see those tolerances pushed up and up and up until they eventually take a too-large, killing dose.There have been numerous efforts to control the flow of fentanyl into the US, and beginning in the mid-20-teens, there were high-profile seizures of the illicitly produced stuff around the country. As of mid-2025, China seems to be the primary source of most illicit fentanyl around the world, the drug precursor produced in China, shipped to Mexico where it's finalized and made ready for market, and then smuggled into the US.There have been efforts to shut down this supply chain, including recent tariffs put on Chinese goods, ostensibly, in part at least, to get China to handle those precursor suppliers.Even if that effort eventually bears fruit, though, India seems to have recently become an alternative source of those precursors for Mexican drug cartels, and for several years they've been creating new markets for their output in other countries, like Nigeria, Indonesia, and the Netherlands, as well.Amidst all that, a new synthetic drug, which is 40-times as potent as fentanyl, is starting to arrive in the US, Europe, and Australia, and has already been blamed for thousands of deaths—and it's thought that that number might be a significant undercount, because of how difficult it can be to attribute cause with these sorts of drugs.Nitazenes were originally synthesized back in the 1950s in Austria, and they were never sold as painkillers because they were known, from the get-go, to be too addictive, and to have a bad tradeoff ratio: a little bit of benefit, but a high likelihood of respiratory depression, which is a common cause of death for opioid addicts, or those who accidentally overdose on an opioid.One nitazene, called isotonitazene, first showed up on US drug enforcement agency radars back in 2019, when a shipment was intercepted in the Midwest. Other agencies noted the same across the US and Europe in subsequent years, and this class of drugs has now become widespread in these areas, and in Australia.It's thought that nitazenes might be seeing a surge in popularity with illicit drugmakers because their potency can be amped up so far, way, way higher than even fentanyl, and because their effects are similar in many ways to heroin.They can also use them they way they use fentanyl, a tiny bit blended into lower-quality versions of other drugs, like cocaine, which can save money while also getting their customers, who may not know what they're buying, hooked, faster. For context, a fifth of a grain of nitazene salt can be enough to kill a person, so it doesn't take much, less than that, if they want to keep their customers alive, to achieve the high they're looking for. A little bit goes a long, long way.This class of drugs is also difficult to detect, which might be part of the appeal for drug makers, right now. Tests that detect morphine, heroin, and fentanyl do not detect natazines, and the precursors for this type of drug, and the drugs themselves, are less likely to be closely watched, or even legally controlled at the levels of more popular opioids, which is also likely appealing to groups looking to get around existing clampdown efforts.Right now, drug agencies are in the process of updating their enforcement and detection infrastructure, and word is slowly getting out about nitazenes and the risk they potentially pose. But it took years for sluggish government agencies to start working on the issue of fentanyl, which still hasn't been handled, so it's anyone's guess as to when and if the influx of nitazenes will be addressed on scale.Show Noteshttps://www.wired.com/story/a-new-type-of-opioid-is-killing-people-in-the-us-europe-and-australia/https://link.springer.com/article/10.1007/BF02161116https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(24)00024-0/fulltexthttps://www.theguardian.com/society/2025/nov/03/nitazenes-synthetic-opioid-drug-500-times-stronger-than-heroin-fatalhttps://www.nature.com/articles/d41586-025-03280-5https://theconversation.com/10-times-stronger-than-fentanyl-nitazenes-are-the-latest-deadly-development-in-the-synthetic-opioid-crisis-265882https://www.cato.org/blog/fentanyl-nitazenes-why-drug-war-keeps-making-danger-worsehttps://www.cfr.org/backgrounder/fentanyl-and-us-opioid-epidemichttps://en.wikipedia.org/wiki/Purdue_Pharmahttps://en.wikipedia.org/wiki/Oxycodonehttps://en.wikipedia.org/wiki/Fentanylhttps://en.wikipedia.org/wiki/Nitazeneshttps://en.wikipedia.org/wiki/Opioidhttps://en.wikipedia.org/wiki/Timeline_of_the_opioid_epidemichttps://en.wikipedia.org/wiki/Opioid_epidemic This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit letsknowthings.substack.com/subscribe

Opioids remain a cornerstone of palliative care for patients with serious illnesses like cancer, yet their use is often misunderstood, undertreated, or approached with unnecessary hesitation. This episode explores what pharmacists need to know about assessing opioid appropriateness, questioning therapy when warranted, and supporting comfort-focused care within established clinical and ethical standards. Tune in to build confidence in your role and contribute meaningfully to the care of patients facing serious illness.HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTLorin Fisher, PharmD, BCACPClinical Assistant ProfessorUniversity of Iowa College of PharmacyJoshua Davis Kinsey and Lorin Fisher have no relevant financial relationships to disclose.Pharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify the role of opioids in managing pain and other symptoms for patients receiving palliative care.2. Describe key considerations for evaluating opioid prescriptions in the context of serious illness, including appropriate use and safety concerns. 0.05 CEU/0.5 HrUAN: 0107-0000-25-330-H01-PInitial release date: 11/10/2025Expiration date: 11/10/2026Additional CPE details can be found here.

Opioids remain a cornerstone of palliative care for patients with serious illnesses like cancer, yet their use is often misunderstood, undertreated, or approached with unnecessary hesitation. This episode explores what pharmacists need to know about assessing opioid appropriateness, questioning therapy when warranted, and supporting comfort-focused care within established clinical and ethical standards. Tune in to build confidence in your role and contribute meaningfully to the care of patients facing serious illness. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTLorin Fisher, PharmD, BCACPClinical Assistant ProfessorUniversity of Iowa College of PharmacyJoshua Davis Kinsey and Lorin Fisher have no relevant financial relationships to disclose. Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify the role of opioids in managing pain and other symptoms for patients receiving palliative care.2. Describe key considerations for evaluating opioid prescriptions in the context of serious illness, including appropriate use and safety concerns. 0.05 CEU/0.5 HrUAN: 0107-0000-25-330-H01-PInitial release date: 11/10/2025Expiration date: 11/10/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

11/09/25The Healthy Matters PodcastS05_E03 - Addiction Recovery in Real Time - LIVE!With Special Guests:  Dr. Lauren Graber and Dr. Charlie ReznikoffAddiction can come in a lot of different forms, and although the opioid epidemic has been at the fore of the conversation, we often forget that cigarettes and alcohol continue to claim the most lives.  Truth is, 1 in 3 Americans is affected in one way or another by someone with a substance use disorder, which is to say that it's not just a problem for the individual with the condition.  But how does one get addicted in the first place?  Who's most at risk?  And what can be done to help them?Addiction is not about willpower or a moral shortcoming, it's actually a complex medical condition that can affect the brain and body, and on the next episode of our show, we'll be joined by addiction medicine specialists Dr. Lauren Graber and Dr. Charlie Reznikoff to help us detangle the matter.  Join us for an insightful conversation (in front of a live studio audience!) with two experts who have helped countless people find help and hope in recovery.Got healthcare questions or ideas for future shows?Email - healthymatters@hcmed.orgCall - 612-873-TALK (8255)Get a preview of upcoming shows on social media and find out more about our show at www.healthymatters.org.

The American Heart Association has new guidance on choking response for infants, children and adults, and for treating individuals with suspected opioid overdose.

November 5, 2025- We check in with Debra Pantin, chair of New York State Opioid Settlement Fund Advisory Board, for an update on the distribution of funds to combat the opioid epidemic and discuss the board's recommendations for 2026.

Opioids. In. The. Chairs. That's the theory, and Ron Trosper is all in. In The Chair Company Episode 4, the paranoia ratchets up as Ron's delusions (or revelations?) send him deeper into Tecca's tangled web of weirdness, broken furniture, and—somehow—modeling scams.Brandon & Chanel break it all down:Flashbacks to Ron & Barb's big dreams — Jeep tours & breast pumps, anyone?Everpump vs. Everfail — the entrepreneurial crash that may have broken RonChair schematics, hydraulic levers, Hungarian exports, and spreadsheet Pepe Silvia madnessA fake-out cop sting… for a Big Green EggThe legendary “Bahld Harmon” beats Ron for a modeling gig (and Ron's ego will never recover)Mistaken yearbook drama that makes the HR investigation so much worseRed balls, tuba mascots, and pop-ups from the Red Ball Market GlobalA Jason-masked figure, waving at a camera next to a lone Tecca chair. Yep.It's True Detective meets I Think You Should Leave in this slow descent into office paranoia and personal failure. Is Ron uncovering a dark pharmaceutical plot? Or is he finally snapping under the weight of suppressed ambition and unresolved trauma?Whatever the truth is — it's absolutely hilarious, and Brandon & Chanel are here for every unhinged moment.

A comprehensive guide on how to complete a thorough history and physical (H+P) for patients presenting to the hospital with opioid withdrawal.00:15 Admission Checklist for Opioid Withdrawal00:40 Triage and Chart Check02:01 Critical Considerations and Admission Orders03:10 Initial Treatment Options for Opioid Withdrawal05:32 Detailed HPI Intake Questions07:33 Physical Exam Notes08:35 Key Takeaways and ConclusionSubscribe to our Substack to receive updates and IM/Hospital Medicine recaps directly to your inbox.POCM Opioid Withdrawal Inpatient AdmissionPOCM Opioid Use Disorder and Withdrawal Clinical Review13 Essential Facts for Managing Opioid Withdrawal in 2025

Each day, SDPB brings you statewide news coverage. We then compile those stories into a daily podcast.

Welcome to the Irreplaceable Dental Team podcast brought to you by DAME - Dental Assisting Made Easy. A safe space to be mentored, empowered, and equipped. We are here to discuss with Tom Viola the opioid crisis and what you as a member of the dental team need to know. Let's learn and stay on the grow! Please remember to subscribe, rate, and share. DAME - Dental Assisting Made Easy. We are better together!A big thank you to local Jamaican artist, Owen Pinnock, for the original music on our podcast.

We talk about Jason's new membership in the over-50 club, where new bits come from, and how opioids may affect that.

On this powerful episode of Taking Authority Over Autism, host Sheletta Brundidge teams up with Your Path Health to tackle the growing impact of opioid use on families and communities. Together, they discuss how education, advocacy, and access to support can help prevent addiction and promote healing. Tune in for an honest, hope-filled conversation about breaking the cycle and building healthier futures.

Tara dives into a mix of pop culture and geopolitics in this episode, starting with family Halloween movie traditions and the cultural significance of the original Halloween films. Then she shifts to breaking political and global news: Trump's efforts to secure SNAP benefits, negotiate trade deals with China, and curb rare earth export restrictions. Tara also highlights a deadly new opioid threat, xylazine, flooding the U.S. from China and other countries, underscoring the ongoing dangers in the drug crisis. From horror movies to global crises, some things are scary—and real. In this episode, Tara shares a family Halloween movie tradition, celebrating the cultural impact of the original Halloween films. She then covers Trump's political moves, including keeping SNAP benefits funded, negotiating trade deals with China, and easing rare earth mineral restrictions critical for U.S. technology. The discussion shifts to the deadly new opioid xylazine, a synthetic drug stronger than fentanyl, showing how international threats continue to endanger Americans. Tara connects pop culture, politics, and public safety, giving listeners a mix of light-hearted family content and urgent news analysis.

The investigation into the death of Celeste Rivas Hernandez, the teen whose badly decomposed body was found in the trunk of a Tesla owned by singer D4vd, is ongoing. Private investigator Steve Fischer has been investigating the case after being hired by the owner of the Hollywood Hills home where D4vd was living. Los Angeles Police are investigating Celeste's death and the medical examiner is awaiting toxicology results before determining manner and cause of death. Law&Crime's Angenette Levy talks with Fischer about his latest findings in this episode of Crime Fix — a daily show covering the biggest stories in crime.PLEASE SUPPORT THE SHOW: If you're ever injured in an accident, you can check out Morgan & Morgan. You can submit a claim in 8 clicks or less without having to leave your couch. To start your claim, visit: https://www.forthepeople.com/CrimeFixHost:Angenette Levy https://twitter.com/Angenette5Guest: Steve Fischer https://x.com/SF_investigatesProducer:Jordan ChaconCRIME FIX PRODUCTION:Head of Social Media, YouTube - Bobby SzokeSocial Media Management - Vanessa BeinVideo Editing - Daniel CamachoGuest Booking - Alyssa Fisher & Diane KayeSTAY UP-TO-DATE WITH THE LAW&CRIME NETWORK:Watch Law&Crime Network on YouTubeTV: https://bit.ly/3td2e3yWhere To Watch Law&Crime Network: https://bit.ly/3akxLK5Sign Up For Law&Crime's Daily Newsletter: https://bit.ly/LawandCrimeNewsletterRead Fascinating Articles From Law&Crime Network: https://bit.ly/3td2IqoLAW&CRIME NETWORK SOCIAL MEDIA:Instagram: https://www.instagram.com/lawandcrime/Twitter: https://twitter.com/LawCrimeNetworkFacebook: https://www.facebook.com/lawandcrimeTwitch: https://www.twitch.tv/lawandcrimenetworkTikTok: https://www.tiktok.com/@lawandcrimeSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode of "New York Public Health Now," Commissioner Dr. Jim McDonald and Executive Deputy Commissioner Johanne Morne are joined by Dr. David Holtgrave as they explore the remarkable story of the cost effectiveness of naloxone in New York State.This episode dives into the real-world impact of naloxone, illuminating stories, budget realities, and lives saved. Learn how New York's overdose prevention and harm reduction programs are changing lives, the science of measuring cost effectiveness, and why ongoing community engagement remains vital.If you have an idea for topics we should discuss, please let us know: PublicHealthNowPodcast@health.ny.gov

Key PointsRod describes his transformation from opioid addiction as "night and day" explaining that he now has hope, a house, and family whereas previously he had nothing.Medical complications began in 2015 when Rod developed gallstones stuck in his pancreatic duct, leading to gallbladder removal surgery followed by seven months of hospitalization with fentanyl, lauded, or morphine administered every four hours.Hospital discharge resulted in doctors prescribing 250-500 pills at a time with instructions to return for more if needed, leading Rod to take twice the recommended dosage without experiencing withdrawal symptoms.Rod died on the operating table during April 2015 surgery with doctors calling his children to say goodbye, but he survived and spent another seven months in the hospital bed receiving intravenous drugs every four hours.Five years of cycling between hospital admissions and discharges followed, with Rod spending 15 months out of two years hospitalized, yet no doctor ever suggested he might be addicted to the medications being administered.Recognition of addiction never occurred to Rod during this period, as he genuinely believed he was sick and had no awareness of his dependency on opioids.A friend's suggestion to try marijuana came after Rod's girlfriend left and he had deteriorated to 150 pounds, appearing gaunt and pale, despite his initial 35-year abstinence from cannabis due to anti-drug beliefs.Cannabis immediately eliminated the nausea, vomiting, and diarrhea that characterized Rod's opioid withdrawal symptoms, which doctors had been misdiagnosing as pancreatitis and treating with more opioids.Additional health improvements from cannabis use included elimination of atrial fibrillation, cessation of cigarette smoking, and complete sobriety from alcohol since 2014.Rod's lowest point involved suicidal ideation until his two-year-old granddaughter sat on his lap and fell asleep, making him realize he couldn't leave her to deal with his death.Multiple family members and friends have died from opioid-related overdoses, including his best friend's son from heroin in 2015, a cousin from fentanyl-laced cocaine on Christmas morning, and two nieces currently struggling with methadone or heroin addiction.Transition from opioids to cannabis occurred overnight without difficulty, and Rod has not required hospitalization since beginning cannabis use, contrasting sharply with his previous constant medical interventions.Rod argues that cannabis serves as a "gateway drug" away from harmful substances toward better health, citing his own experience and noting that marijuana withdrawal causes only temporary irritability without life-threatening complications.All of Rod's current doctors are aware of his cannabis use and none have advised him to stop, though they have recommended against alcohol consumption, suggesting medical professionals recognize cannabis benefits despite legal restrictions. Visit our website: CannabisHealthRadio.comFind high-quality cannabis and CBD + get free consultations at MyFitLife.net/cannabishealthDiscover products and get expert advice from Swan ApothecaryFollow us on Facebook.Follow us on Instagram.Find us on Rumble.Keep your privacy! Buy NixT420 Odor Remover Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Secretary of the Department of Drug and Alcohol Programs for the Commonwealth of Pennsylvania, Dr. Latika Davis-Jones joins our host Heather Major for episode 4 of Someone You Know.  This episode was recorded in September 2025, National Recovery Month. In this episode, we discuss: ● How Dr. Davis-Jones is leading the charge in elevating the power of recovery in Pennsylvania. ● The resource implementations the state is making to showcase that recovery is possible, and that there is hope. ● The importance of connectedness within communities of all demographics. ● And, the statewide engagement tour Dr. Davis-Jones is currently on To learn more about the Life Unites Us campaign, visit www.LifeUnitesUs.com. For 24/7 access to the Pennsylvania Get Help Now hotline, that phone number is 1-800-662-HELP. Hosted by Heather Major, Executive Director, Independence Blue Cross Foundation. Recovery is possible, and help is available. Please visit our website to learn how we are collaborating to address this crisis: www.ibxfoundation.org. TM 2025 Someone You Know®. All Rights Reserved. Disclaimers The information contained in this podcast is solely for informational purposes and should not replace advice from a medical provider when making healthcare decisions. This podcast contains opinionated content and may not reflect the opinions of any organizations this podcast is affiliated with. Nothing discussed in this podcast shall constitute or should be construed as endorsement by the Independence Blue Cross Foundation or Independence Blue Cross, LLC of any product or service discussed herein. We will discuss opioid use and opioid treatment, which may be triggering for some listeners. Listener discretion is advised. If you or someone you know is suffering from opioid addiction, please visit ibxfoundation.org/SYK.

Hugo Toovey has beaten cancer, twice. But this is far from the whole story.

Each day, SDPB brings you statewide news coverage. We then compile those stories into a daily podcast.

Well, no one was expecting this. Join me as some of our most advanced machines fall to spineless hoards and for a villain-turned-almost-good-guy.— Support and sponsor this show! Venmo Tip Jar: @wellthatsinteresting Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@wellthatsinterestingpod⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Bluesky: @wtipod Threads: @wellthatsinterestingpod Twitter: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@wti_pod⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Listen on YouTube!! Oh, BTW. You're interesting. Email YOUR facts, stories, experiences... Nothing is too big or too small. I'll read it on the show: wellthatsinterestingpod@gmail.com WTI is a part of the Airwave Media podcast network! Visit AirwaveMedia.com to listen and subscribe to other incredible shows. Want to advertise your glorious product on WTI? Email me: wellthatsinterestingpod@gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Although opioid overdose deaths have recently declined, tens of thousands of families still lose loved ones to the epidemic each year. Overcoming the epidemic requires a comprehensive approach that spans education and prevention, treatment and recovery, justice reform, cross-sector collaboration, and supportive policies. How can communities integrate these areas effectively to save lives and support long-term recovery?  In this episode of the Leading Voices podcast, host Grace Westermann speaks with Jennifer Loeffler-Cobia, Director of Justice and Public Health Policy and Practice at WestEd's Justice and Prevention Research Center. They discuss the root causes of youth opioid misuse; the barriers that prevent schools, healthcare, law enforcement, and community organizations from working together; and the role of data in building coalitions that are more effective.   Drawing on her expertise, Loeffler-Cobia outlines five evidence-based strategies for addressing the epidemic and explains why breaking down silos across sectors is critical to saving lives.  Their conversation covers the following topics:  Why schools are critical sites for spreading awareness and reaching youth through education and prevention programs  How comprehensive care addresses medical, mental health, housing, and employment needs in treatment and recovery services  How drug courts and diversion programs balance accountability with rehabilitation as alternatives to incarceration  Why breaking down silos across sectors and building coalitions that share resources and use data effectively is essential  How supportive policies, sustained funding, and evidence-based practices can drive lasting change through legislative reform  Resources From This Episode WestEd Justice and Prevention Research Center  Addressing the Opioid Overdose Epidemic

Moderator: BobbieJean Sweitzer, M.D. Participants: Rutger van der Schrier, M.D., Ph.D. and Steven L. Shafer, M.D Articles Discussed: Fentanyl-induced Ventilatory Depression: Population Pharmacokinetic–Pharmacodynamic Framework for Evaluation of Opioid-induced Ventilatory Depression Toward More Physiologic Models for Predicting the Impact of Opioids on Ventilation

For years, doctors and those learning to practice medicine were told pain is "the fifth vital sign" and to treat it aggressively – including with opioids, "if that's what it takes." A consequent rise in opioid prescribing contributed to the devastating opioid crisis. Then the pendulum swung in the opposite direction, hard, with physicians cutting off opioid prescribing to patients, often without their consent. That too led to suffering with many deaths by suicide. What do these two seemingly opposing trends share in common? Both reflect a failure to embrace current knowledge about chronic pain and to bring compassion and caring to people who are suffering. Co-hosts Saul Weiner and Stefan Kertesz discuss the implications from two perspectives: Medical learners are still taught to treat chronic pain like a simple bodily injury ("somatically") with the caveat to avoid opioids, spurring apathy and frustration. Stefan, an addiction medicine specialist who has been conducting a national study of suicides related to forced opioid tapers, argues that we have "become addicted to talking about opioids" rather than about all the good we could do if we applied current knowledge and compassion to help people who are suffering.

Each day, SDPB brings you statewide news coverage. We then compile those stories into a daily podcast.

Lifelong Kentucky farmer expresses his concern amid the United States' trade dispute with China, Kentuckians working on the front lines of drug treatment, harm reduction, and prevention convene in Louisville, and some Kentucky high school students are getting a course on how to cover the cost of college.

About this episode: Buprenorphine is a highly effective medication used for treating opioid use disorder. But accessing this lifesaving prescription can be challenging. In this episode: Jeff Hom and Marlene Lira talk about the critical role of buprenorphine in reducing overdose deaths and the role pharmacies can play in improving access. Guests: Jeff Hom, MD, MPH, is the Medical Officer for Science and Policy in the Substance Use Services section of the San Francisco Department of Public Health. He is also a DrPH student in Health Policy and Bloomberg Fellow at the Johns Hopkins Bloomberg School of Public Health. Marlene C. Lira, MPH, is the Senior Director of Research at Workit Health, a multi-state telemedicine treatment provider for evidence-based addiction care, and a doctoral candidate in Health Policy & Management at the Johns Hopkins Bloomberg School of Public Health. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: Pharmacy Barriers to Receiving Buprenorphine Among Patients Undergoing Telemedicine Addiction Treatment—JAMA Network Open Prescribing Buprenorphine By Telehealth: Lessons From San Francisco Amidst A Changing Regulatory Landscape—Health Affairs The New Federal Regulations Aimed Making Methadone More Accessible—And Less Stigmatizing—Public Health On Call (April 2024) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Medications for Opioid Use Disorder Playbook Agency for Healthcare Research and Quality (AHRQ)  The AHRQ Integration Academy developed the Medications for Opioid Use Disorder Playbook as a practical guide for providing medications for opioid use disorder (MOUD) and immediate care for patients with OUD in primary care and other ambulatory care settings. It is interactive, web-based, and has the latest guidance, tools, resources, and examples that address key aspects of MOUD implementation. The MOUD Quick Start Guide covers the essentials of low-threshold care, while the balance of the Playbook offers more in-depth resources and guidance for those practices interested in working toward more comprehensive, whole-person care. The low-threshold approach ensures immediate access to MOUD, eliminating barriers for both patients and providers.    Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM

Triple-board-certified anesthesiologist and pain-management specialist Dr. Akash Bajaj joins May and Tim Hindmarsh to share his journey from traditional pain medicine to functional and regenerative care. He recalls being a 9/11 first responder, his shift away from opioid-based practice, and how therapies like PRP and stem-cell injections are transforming recovery for patients. The conversation dives deep into mindset, hormones, and the art of true healing—without dependence on prescriptions.Guest BioDr. Akash Bajaj, MD, MPH is a triple board-certified physician in Anesthesiology, Pain Medicine, and Regenerative Medicine, based in Los Angeles, California. He is the founder and medical director of Axxor Medicine, where he integrates traditional pain management with cutting-edge regenerative and functional medicine therapies.A graduate of New York Medical College, Dr. Bajaj completed his anesthesiology residency at UCLA and his pain management fellowship at UC San Francisco. His experience as a first responder during 9/11 deeply shaped his perspective on patient suffering and inspired his lifelong focus on pain relief and healing.Today, Dr. Bajaj specializes in non-opioid treatments such as PRP (platelet-rich plasma), stem cell therapy, and hormone optimization, helping patients address the root causes of chronic pain, aging, and inflammation. His mission is to restore function, vitality, and quality of life through a personalized, whole-body approach to medicine.Website: https://axxormedicine.com GET SOCIAL WITH US!

Gov. Kathy Hochul says the White House is clawing back money to support patrols, security camera operations and K-9 units for the city's transit system. Plus, the NYPD's top officer is retiring a week after Mayor Adams ended his re-election bid. And finally, Democrat Mikie Sherrill and Republican Jack Ciattarelli squared off in a fiery debate Wednesday night tackling topics like the Gateway Tunnel Project and New Jersey Transit service.

Canadian journalist Nora Loreto reads the latest headlines for Wednesday, October 8, 2025.TRNN has partnered with Loreto to syndicate and share her daily news digest with our audience. Tune in every morning to the TRNN podcast feed to hear the latest important news stories from Canada and worldwide.Find more headlines from Nora at Sandy & Nora Talk Politics podcast feed.Help us continue producing radically independent news and in-depth analysis by following us and becoming a monthly sustainer.Follow us on:Bluesky: @therealnews.comFacebook: The Real News NetworkTwitter: @TheRealNewsYouTube: @therealnewsInstagram: @therealnewsnetworkBecome a member and join the Supporters Club for The Real News Podcast today!WE'RE FINALISTS FOR THE PRESTIGIOUS SIGNAL AWARDS. HELP US WIN!Click here to vote!:https://vote.signalaward.com/PublicVoting#/2025/shows/genre/historyMichael Fox is also a finalist in the History Podcast category for his truly unique, rich, and inspirational weekly series Stories of Resistance------------Click here to vote for Marc Steiner!: https://vote.signalaward.com/PublicVoting#/2025/individual-episodes/cMarc Steiner is a finalist for Best Host of an Individual Episode 

Opioid poisonings have killed tens of thousands across Canada, the vast majority of them adults. But, in a heartbreaking group of cases, babies and toddlers have fallen victim to fentanyl or its more toxic cousin carfentanil. Sharon Kirkey joins the show to discuss how many young children have died from opioid overdoses. Learn more about your ad choices. Visit megaphone.fm/adchoices

We're back with more powerful research on this week's episode of The Evidence Based Chiropractor. If you care about your patients' health and the opioid crisis, this is a must-read.Here's the Big News:A brand new study published in 2025 shows that patients who choose chiropractic care first for new low back pain are an astonishing 80% less likely to develop an opioid use disorder, compared to those who reach for ibuprofen and follow the typical medical pathway.Let's break down the study highlights:Dramatic risk reduction: Only 0.24% of patients who consulted a chiropractor developed opioid use disorder — versus 1.5% in the ibuprofen group.Prescription impact: Chiropractic patients not only had a significantly lower risk of addiction but also received less than half the average number of opioid prescriptions compared to the ibuprofen group.Long-term safety: Long-term opioid use (90+ days) was 77% lower among chiropractic patients.Episode Notes: Association Between Spinal Manipulative Therapy for Low Back Pain With or Without Sciatica and Opioid Use DisorderLeander Tables- Save $1,000 on the Series 950 Table using the code EBC2025 — their most advanced flexion-distraction tablePatient Pilot by The Smart Chiropractor is the fastest, easiest to generate weekly patient reactivations on autopilot…without spending any money on advertising. Click here to schedule a call with our team.Our members use research to GROW their practice. Are you interested in increasing your referrals? Discover the best chiropractic marketing you aren't currently using right here!

Ben Bush, a former U.S. Army Ranger combat veteran from Brandon, shares with Mississippi Today his personal story of his struggle with PTSD after returning home from overseas combat, and how the psychedelic plant-derived drug ibogaine helped him regain his life. But he had to travel to Mexico for the treatment. It's illegal in the United States. House Public Health Chairman Sam Creekmore wants to change that, and he wants Mississippi to invest in testing the drug and help push for federal approval. 

In this episode, Dr. Asif Ilyas, Orthopaedic Surgeon and President of the Rothman Opioid Foundation, shares strategies to reduce opioid reliance while ensuring effective pain management. He discusses multimodal approaches, patient education, and the ongoing challenges of fentanyl and overdose deaths.

In this episode, Dr. Asif Ilyas, Orthopaedic Surgeon and President of the Rothman Opioid Foundation, shares strategies to reduce opioid reliance while ensuring effective pain management. He discusses multimodal approaches, patient education, and the ongoing challenges of fentanyl and overdose deaths.

In this episode, Dr. Asif Ilyas, Orthopaedic Surgeon and President of the Rothman Opioid Foundation, shares strategies to reduce opioid reliance while ensuring effective pain management. He discusses multimodal approaches, patient education, and the ongoing challenges of fentanyl and overdose deaths.

Content Editor Stasia DeMarco speaks with Claire Bryant, Senior Program Manager of Workplace Safety Programs at the National Safety Council, about a new tool designed to help manage the opioid epidemic in the workplace. With overdoses now linked to nearly one in ten workplace deaths, NSC has launched a free Overdose Emergency Planning Tool to help employers prepare for opioid emergencies and determine how much naloxone to keep on hand. Bryant also highlights the importance of quick response and recovery-supportive workplace policies to save lives and prevent future crises.      

In this powerful DiepCJourney® podcast episode, Dr. Anne Peled and Dr. Ziv Peled, renowned experts in breast reconstruction and pain management join forces to explore the groundbreaking potential of Journavx, a new non-opioid oral pain medication designed to address acute post-surgical pain. With a shared commitment to improving patient outcomes and reducing reliance on opioids, this is the first FDA approved non-opioid oral pain medication for acute pain approved by the FDA in twenty years. They unpack the science behind Journavx, its clinical applications, and what it means for the future of recovery after breast reconstruction. Listeners will gain:

In this episode of Laughing with Letta, Sheletta Brundidge speaks with Washington County Health about how opioid settlement funds are being put to work. The county has partnered with eight local organizations to provide support, resources, and hope for families impacted by the opioid crisis. Together, they're building a stronger, healthier community. Tune in to hear how these partnerships are making a real difference on the ground.

Join Dr. Gail Donofrio, an emergency physician and addiction specialist, as she leads a compelling discussion with Dr. Nick Simpson and Dr. Gerard Carroll about the transformative impact of EMS-initiated buprenorphine on opiate overdose care. The panel explores the development of this innovative practice, the successes and challenges encountered, the importance of reframing opioid use disorder as a medical issue, and concrete steps for implementation. Learn about the vital role of pre-hospital providers in bridging treatment gaps and improving patient outcomes. This essential session is part of the SAEM podcast series on EMS-initiated buprenorphine, funded by SAMHSA.   Funding for this initiative was made possible (in part) by grant no. 1H79TI086770 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Opioid overdose is the #1 killer of 18-45 year olds in America. The crisis is not over, and we are still prescribing these addictive substances for pain management at an ...

Text Dr. Lenz any feedback or questions Checkout the video here.Opioids and Fibromyalgia: Understanding the Risks and AlternativesIn this episode of the Conquering Your Fibromyalgia podcast, the host delves into the complex and often controversial topic of using opioids for treating fibromyalgia. The discussion is anchored around a comprehensive review from the Mayo Proceedings and explores why opioids, despite being widely prescribed, are not effective for fibromyalgia patients and may even be harmful. The podcast also covers the mechanisms of fibromyalgia, how it differs from other pain disorders, and why alternative treatments such as FDA-approved medications, exercise, sleep management, and cognitive behavioral therapy are more effective. Listeners are encouraged to seek professional medical advice before making any changes to their treatment plans.00:00 Introduction to Opioids and Fibromyalgia01:23 Understanding Fibromyalgia and Opioid Use03:18 Medical Guidelines and Opioid Efficacy05:39 Neuroimaging Insights and Opioid Hyperalgesia07:28 Expert Opinions and Alternative Treatments08:28 Reasons for Continued Opioid Prescriptions09:27 Psychological and Social Factors10:26 Moving Forward: Multidisciplinary Care12:14 Guidance for Current Opioid Users16:24 Final Thoughts and Encouragement Support the showWhen I started this podcast—and the book that came before it—I had my patients in mind. Office visits are short, but understanding complex, often misunderstood conditions like fibromyalgia takes time. That's why I created this space: to offer education, validation, and hope. If you've been told fibromyalgia “isn't real” or that it's “all in your head,” know this—I see you. I believe you. You're not alone. This podcast aims to affirm your experience and explain the science behind it. Whether you live with fibromyalgia, care for someone who does, or are a healthcare professional looking to better support patients, you'll find trusted, evidence-based insights here, drawn from my 28+ years as an MD. Please remember to talk with your doctor about your symptoms and care. This content doesn't replace personal medical advice.* ...

Pennsylvania Montgomery County Commissioner Jamila Winder  joins our host Heather Major for episode 3 of Someone You Know.   This episode was recorded in May 2025 in front of a live studio audience. In this episode, we discuss: The vast career of Commissioner Winder, spanning various roles in health and human services, particularly with underserved populations The personal connection that influenced her choice to join this line of work. The innovative and strategic ways Montgomery County is striving to use the opioid settlement dollars, to make a real impact. Collegiate Recovery Programs - and how 4 institutions in Montgomery County alone have implemented this program. The importance of Connection in the substance use recovery journey Hosted by Heather Major, Executive Director, Independence Blue Cross Foundation. Recovery is possible, and help is available. Please visit our website to learn how we are collaborating to address this crisis: www.ibxfoundation.org. TM 2025 Someone You Know®. All Rights Reserved. Disclaimers The information contained in this podcast is solely for informational purposes and should not replace advice from a medical provider when making healthcare decisions. This podcast contains opinionated content and may not reflect the opinions of any organizations this podcast is affiliated with. Nothing discussed in this podcast shall constitute or should be construed as endorsement by the Independence Blue Cross Foundation or Independence Blue Cross, LLC of any product or service discussed herein. We will discuss opioid use and opioid treatment, which may be triggering for some listeners. Listener discretion is advised. If you or someone you know is suffering from opioid addiction, please visit ibxfoundation.org/SYK. 

Health Affairs' Rob Lott interviews Elizabeth Van Nostrand of Temple University about her recent paper exploring how Indiana adults participating in treatment court program tended to have better health outcomes than individuals who applied and were accepted but chose not to participate.Order the September 2025 issue of Health Affairs.Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcast

Grow your management tools for opioid withdrawal in the hospital. Investigate how to decide between methadone and buprenorphine, additional medications to manage symptoms and how and when to use short-acting opioids for management of withdrawal. We're joined by Ashish Thakrar, MD at the University of Pennsylvania.  Claim CME for this episode at curbsiders.vcuhealth.org! By listening to this episode and completing CME, this can be used to count towards the new DEA 8-hr requirement on substance use disorders education. Episodes | Subscribe | Spotify | iTunes | CurbsidersAddictionMed@gmail.com | CME! Show Segments Intro, disclaimer, guest bio Guest one-liner Case from Kashlak; Definitions Symptoms of opioid withdrawal Medications for the management of opioid withdrawal Buprenorphine precipitated withdrawal Starting Buprenorphine: Experiences and Strategies  Titrating Methadone: Dosage and Adjuncts Adjunctive short-acting opioids Emerging Trends in Drug Supply: Xylazine and Medetomidine Outro  Credits Producer, Show Notes: Zina Huxley-Reicher Infographics: Zina Huxley-Reicher MD and Zoya Surani Hosts: Carolyn Chan, MD MHS, Zina Huxley-Reicher MD, Shawn Cohen, MD Reviewer: Payel Jhoom Roy, MD, MSc Showrunner: Carolyn Chan, MD, MHS Technical Production: PodPaste Guest: Ashish Thakrar, MD MHSP Sponsor: Mint Mobile  Shop plans at MINTMOBILE.com/CURB Sponsor: Freed Use code: CURB50 to get $50 off your first month when you subscribe! Sponsor: FIGS  We've teamed up with FIGS, and now Curbsiders listeners can get 15% off. Just go to WearFIGS.com and use code FIGSRX.

About this episode: This July, a dangerous influx of opioids triggered two mass overdose events in the Penn North neighborhood of Baltimore. A swift and nimble response from the city and community stakeholders resulted in zero fatalities. In this episode: Dr. Letitia Dzirasa and Sara Whaley from the City of Baltimore explain what happened, detail the multipronged emergency response, and share how the city plans to move forward in addressing the opioid crisis. Guest: Dr. Letitia Dzirasa is the Deputy Mayor of Health and Human Services with the City of Baltimore. Sara Whaley, MPH, MSW, is the executive director of the City of Baltimore's Overdose Response Team. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: Overdose Response Strategic Plan—City of Baltimore Community leaders, experts address Baltimore's overdose crisis—WEAA Baltimore mass overdose: 'Coordinated neighborhood stabilization response' launched in Penn-North—WBAL Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

When a company's values don't match its actions, the impact can be devastating. Kim and Amy speak with investigative journalist Gardiner Harris about his book, No More Tears: The Dark Secrets of Johnson & Johnson. Harris uncovers how a company once seen as the gold standard of integrity used its famous “Credo” to build emotional trust while covering up harmful practices—from baby powder linked to cancer to its role in the opioid crisis. The conversation goes beyond one company, raising bigger questions about accountability, transparency, and the systems meant to keep us safe. It's a candid look at how misplaced trust can cause lasting damage—and what it really takes to create a culture where honesty and responsibility come first. Get all of the show notes at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠RadicalCandor.com/podcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Episode Links:⁠⁠⁠⁠⁠⁠⁠⁠⁠ Gardiner Harris No More Tears: The Dark Secrets of Johnson & Johnson  The Weekly | A Secret Opioid Memo That Could Have Slowed an Epidemic | The New York Times A Devastating New Exposé of Johnson & Johnson Indicts an Entire System | The New Republic The Johnson & Johnson Cancer Drug Scandal That Encapsulates Corruption In Health Care | STAT News J&J Is Back On The Legal Warpath After Striking Out In Baby Powder Bankruptcy | Reuters Antipsychotic Drugs and Nursing Home Residents: What Do the Different Numbers Mean? | Center for Medicare Advocacy Empire of Pain: The Secret History of the Sackler Dynasty The Least of Us: True Tales of America and Hope in the Time of Fentanyl and Meth  Physician Payments Sunshine Act (also known as the Open Payments program) Watch Cold Case: The Tylenol Murders | Netflix  Connect: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Website⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Bluesky⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Chapters: (00:00:00) Introduction Kim and Amy introduce Gardiner Harris, investigative journalist and author. (00:01:01) No More Tears Why Gardiner's book hasn't been widely covered by the media. (00:07:35) Hidden Dangers of Products Overview of Johnson & Johnson's vast range of dangerous products. (00:15:13) Antipsychotics in Nursing Homes How antipsychotics were pushed to sedate elderly patients. (00:16:58) Opioids & Corporate Responsibility The role Johnson & Johnson played in the opioid epidemic. (00:24:04) The Power of Branding & Emotional Trust The exploitation of emotional branding to avoid accountability. (00:27:28) Incentives, Conflicts, & Complicity How financial incentives corrupted doctors, researchers, and hospitals (00:39:12) Breaking Points & Speaking Up Stories about the individuals affected by Johnson & Johnson. (00:47:27) The Cult of the Credo How J&J weaponized its corporate credo to silence whistleblowers. (00:52:19) How J&J Got Away With It The ways J&J avoided accountability and hid decades of misconduct. (00:57:36) Tylenol, Safety, & the Illusion of Trust The FDA's inability—or unwillingness—to enforce safety despite evidence. (01:03:29) Hope, Oversight & Individual Action How individual action and awareness can drive systemic change. (01:08:10) Conclusion Learn more about your ad choices. Visit megaphone.fm/adchoices

American's are dying by overdose in record numbers, victims of the worst opioid addiction epidemic in history. In Mobile, Alabama two doctors are serving up heavy doses of the dangerous drugs. One drug the doctors prescribe is 50 times more potent than heroin and the multi-billion dollar drug company that makes it is paying them to push it. While both the drug maker and these doctors are unrelenting in turning patients' pain into enormous profits, some families of those who die hold the doctors responsible. (Original television broadcast: 3/5/2018) Want to binge watch your Greed? Full episodes and the latest news at: https://www.cnbc.com/american-greed/

LightSpeed VT: https://www.lightspeedvt.com/ Dropping Bombs Podcast: https://www.droppingbombs.com/ What if the natural cure you've been searching for has been buried under decades of propaganda and misinformation? In this episode of Dropping Bombs, I sit down with William O'Boyle – former college athlete, recovered addict, and founder of Meda Leaf Farms – to unpack the truth about CBD, CBG, hemp, and how these natural compounds are transforming lives. With RFK championing plant-based healing, they explore why hemp could be the key to real wellness.   William shares his powerful story of battling opioid addiction, overcoming a near-death experience, and how one gummy opened the door to a new life. Brad and William dive into CBD benefits for sleep, anxiety, ADHD, CTE, and pain relief, plus why the endocannabinoid system is one of the most overlooked parts of your health. They also expose the history of hemp criminalization, the industries that killed it, and why it's time to reclaim your health using plant-based medicine.